Wei‐Jan Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 3
-
- Ferroptosis and cancer prognosis 5
- Co-authors
- Wei‐Wen Kuo (2 shared papers)Mien‐Chie Hung (15 shared papers)Chien‐Feng Li (4 shared papers)Chih‐Yang Wang (9 shared papers)Hsi‐Hsien Hsu (1 shared paper)Gangga Anuraga (10 shared papers)Cheng‐Wen Lin (3 shared papers)Hoang Dang Khoa Ta (10 shared papers)
- Journals
- International Journal of Medical Sciences (3 papers)Journal of Personalized Medicine (3 papers)American Journal of Cancer Research (2 papers)International Journal of Biological Sciences (2 papers)Aging (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei‐Jan Wang
38 papers receiving 831 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 151
- Molecular Biology 419
- Complementary and alternative medicine 41
- Immunology 98
- Biochemistry 26
Countries citing papers authored by Wei‐Jan Wang
This map shows the geographic impact of Wei‐Jan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jan Wang more than expected).
Fields of papers citing papers by Wei‐Jan Wang
This network shows the impact of papers produced by Wei‐Jan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jan Wang. The network helps show where Wei‐Jan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Jan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 99 | |
| 2 | 2012 | 89 | |
| 3 | Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease | 2020 | 66 |
| 4 | 2021 | 58 | |
| 5 | 2016 | 51 | |
| 6 | 2013 | 37 | |
| 7 | 2015 | 37 | |
| 8 | 2016 | 32 | |
| 9 | 2021 | 31 | |
| 10 | 2014 | 25 | |
| 11 | 2015 | 25 | |
| 12 | 2021 | 24 | |
| 13 | 2021 | 23 | |
| 14 | Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma. | 2020 | 21 |
| 15 | 2021 | 19 | |
| 16 | Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2. | 2022 | 16 |
| 17 | 2021 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2022 | 13 |
About Wei‐Jan Wang
Wei‐Jan Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases, Cancer Research and Oncology, having authored 42 papers that have together received 842 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (5 papers), Computational Drug Discovery Methods (5 papers), Ferroptosis and cancer prognosis (5 papers), COVID-19 Clinical Research Studies (4 papers), RNA Research and Splicing (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (151 citations), Molecular Biology (419 citations), Complementary and alternative medicine (41 citations), Immunology (98 citations) and Biochemistry (26 citations). Wei‐Jan Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wei‐Wen Kuo, Mien‐Chie Hung, Chien‐Feng Li, Chih‐Yang Wang, Hsi‐Hsien Hsu, Gangga Anuraga, Cheng‐Wen Lin, Hoang Dang Khoa Ta, Pei‐Ying Pai and Tung‐Yuan Lai. Their work appears in journals such as International Journal of Medical Sciences, Journal of Personalized Medicine, American Journal of Cancer Research, International Journal of Biological Sciences and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.